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Introduction
In humans and some other mammals, the composition of hemoglobin tetramers in erythrocytes switch from fetal hemoglobin (HbF, α 2γ2) to adult hemoglobin (HbA, α 2β2) during the last stages of fetal development until early infancy 1 . HbF is the most important known modifier of the clinical symptoms for patients with sickle cell disease (SCD) and β -thalassemias, which are among the most common genetic disorders worldwide 2, 3 . In patients with SCD, the polymerization of sickle hemoglobin results in erythrocyte deformation and hemolysis 4 . SCD patient's clinical outcomes are largely improved by inhibition of the polymerization by HbF 5 . In β -thalassemias, decreased production of beta-globin causes imbalanced globin polypeptide chain synthesis, and leads to severe effects on the erythroid cells' maturation and survival. The loss of beta-globin expression may be compensated by an increase in HbF production that leads to improvement of the clinical phenotype 6 .
The molecular mechanisms underlying the switch from fetal to adult hemoglobin are still largely unknown. Genome-wide association studies (GWAS) in both normal individuals and patients with β -hemoglobinopathies have identified BCL11A, HSB1L-MYB and HBB clusters as having an association with the persistence of HbF in adults [7] [8] [9] [10] . Suppression of the BCL11A transcription factor causes an increase in HbF levels 11 .
Lin28 is a highly conserved gene that is expressed in the early stages of development of multicellular organisms. In the nematode, C. elegans, lin28 regulates developmental timing at the larvae L2 stage 12 . Mammals express two homologs of the C. elegans lin28 gene known as LIN28A and LIN28B 13, 14 . Human LIN28 genetic variation correlates with developmental timing characteristics such as variation in height 15 , timing of puberty [16] [17] [18] and age at natural menopause 16 .
The effects of LIN28 proteins depend, in part, on the cell type in which it is expressed, as evidenced by its role in promoting the pluripotency of stem cells 19 , as well as the differentiation of skeletal muscle cells 20 .
In part, LIN28 acts through the 3' end uridylation of the precursor molecule pre-let-7, ultimately leading to the degradation of miRNA molecules [21] [22] [23] . Interestingly, expression of the let-7 family of miRNAs was correlated with the fetal-to-adult developmental transition in circulating human reticulocytes 24 . Those data suggest a potential link between LIN28B
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Moreover, a predicted fetal stage-specific enhancer for LIN28B was identified using human primary erythroid cells 26 , and in murine lymphocytes, Lin28b expression regulates the fetal-like phenotype 27 . Here we investigated LIN28B as a candidate regulator of the fetal-to-adult transition of hemoglobin expression and the erythroblast phenotype using an experimental approach developed for ex vivo engineering of human erythrocytes.
Methods
Cell culture. All related studies were performed after human subjects review and NIH IRB approval. These studies were conducted in accordance with the Declaration of Helsinki. Human cord blood CD34+ cells were obtained from All Cells (Emeryville, CA) and ReachBio LLC (Seattle, WA). For the ex vivo culture, a 21 day serum-free system consisting of three phases was utilized. During phase I of culture (day 0 to day 7): adult or cord blood CD34+ cells were placed in media containing StemPro-34 complete media (L-glutamine, pen-strep and StemPro-34 nutrient supplement) (Invitrogen, Carlsbad, CA) with 50 ng/ml SCF (HumanZyme, Chicago, IL), 50 ng/ml FLT3 Ligand (HumanZyme) and 10 ng/ml IL-3 (HumanZyme). After phase I, the cells were transferred to phase II (day 7 to day 14). During this expansion phase, the cell count was monitored on days 9, 11 and 14 to maintain cell counts under 2x10 6 cells per ml. Phase II medium is comprised of the following: StemPro-34 complete medium, 4 U/ml EPO (Amgen, Thousand Oaks, CA), 10 ng/ml SCF, 10 µg/ml insulin (Sigma Aldrich, St. Louis, MO), 3 U/ml heparin (Hospira, Lake Forest, IL) and 0.8 mg/ml holo transferrin (Sigma Aldrich). On culture day 14, cells were counted and transferred to phase III media at 8x10 5 cells per ml for the remaining 7 days of culture. Phase III medium is comprised of the following: StemPro-34 complete medium, 4 U/ml EPO, 3 µM RU486 (Sigma Aldrich), 10 µg/ml insulin, 3 U/ml heparin and 0.8 mg/ml holo transferrin. Recombinant viral transduction. Human LIN28B was subcloned into an MSCV-IRES-Puro based vector as previously described 27 . Human LIN28A over-expression lentiviral particles were purchased from Qiagen (Valencia, CA), and used for comparison studies. Human LIN28B knockdown clones were purchased from Sigma Aldrich. BCL11A knockdown clones were selected as previously described 11 . A micro-RNA sponge experimental approach was utilized for suppression of let-7 28 . The let-7 sponge plasmid (MSCV puro let-7 sponge) was purchased from was added to the culture. On culture day 7, cells were transferred to phase II medium containing EPO and puromycin until culture day 9. After culture day 9, cells were cultivated at the conditions described above without puromycin.
Flow Cytometry analyses.
Immunostaining with antibodies directed against CD71 and glycophorin A (Invitrogen) were performed to assay erythroid differentiation on culture day 21 as previously described 29 HPLC for adult and fetal hemoglobins. Samples for HPLC were prepared and analyzed as previously described 29 .
Quantitative PCR analysis. Q-RT-PCR assays and PCR conditions were performed as described previously 30 . Additional primers and probes used in this study are described in Supplemental 
Results

LIN28B binds primary let-7 transcripts and regulates fetal hemoglobin in human cord
blood CD34+ cells. We previously reported that decreased fetal hemoglobin expression in adult human reticulocytes compared to those present in cord blood is associated with increased let-7 levels in adult reticulocytes 24 . Since let-7 microRNA expression is down-regulated by LIN28
protein binding, the absence of LIN28B expression in adult human bone marrow compared to its detection in fetal liver 27 suggests that both LIN28B and let-7 are developmentally regulated in erythroid tissues. Initial studies were performed to determine if LIN28B binds endogenous let-7 primary transcripts in cord blood derived erythroblasts. RNA immunoprecipitation in CD34+
cord blood lysates was performed and quantitated by RT-PCR for primary let-7d. Let-7d was chosen based upon its expression level in cord blood cells 24 . Primary let-7d was enriched by LIN28B immunoprecipitation compared to the IgG control ( Figure 1A ). 
LIN28B expression activates fetal hemoglobin during adult human erythropoiesis. In addition to studies of cord blood derived erythroblasts, LIN28B expression in adult erythroblasts
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From 8 was examined. When compared to the cord blood erythroblasts, adult erythroblasts demonstrated a major reduction in LIN28B expression (0.1 ± 0.4 copies/ng). To increase LIN28B expression, the cells were transduced with a retrovirus encoding LIN28B. LIN28B over-expression (LIN28B-OE) was confirmed by Q-RT-PCR (LIN28B-OE: 1.8E+04 ± 3.5E+02 copies/ng, p=0.01) and Western analyses (Figure 2A-B) . In transduced erythroblasts, LIN28B was expressed predominantly in the cytoplasm without distinct nuclear localization as shown by confocal microscopy ( Figure 2C-F) .
Erythroblast differentiation and the patterns of hemoglobin expression were compared between control and LIN28B-OE cells. Flow cytometric analysis of erythroblast plasma membrane markers, transferrin receptor (CD71) and glycophorin A (GPA), were performed at culture days 14 and 21 for erythroblast differentiation ( Figure 3A-D) . Surprisingly, LIN28B-OE did not overtly affect erythroid cell maturation when compared to empty vector controls. in LIN28B-OE cells, globin gene expression patterns were quantitated by Q-RT-PCR. The expression levels of alpha, mu, theta, zeta, beta, delta, gamma and epsilon globin genes were evaluated for LIN28B-OE and compared to controls. As shown in Figure 4A -B, only the fetal gamma-globin mRNA expression is significantly heightened with LIN28B-OE (control: 5.1E+06 ± 2.6E+06 copies/ng, LIN28B-OE: 1.8E+07 ± 5.8E+06 copies/ng, p=0.04). The increased expression of gamma-globin was balanced by reductions in beta-globin and delta-globin. No changes were observed in alpha, mu and theta globins, and the low-level expression patterns of zeta and epsilon globins indicated only minor increases.
The fetal-to-adult transition in humans is further characterized by an increase in the carbonic anhydrase I (CA1) gene expressed in erythrocytes 31 , as well as the carbohydrate modification due to the augmented expression of glucosaminyl (N-acetyl) transferase 2 (GCNT2) [32] [33] [34] . Expression of CA1 and GCNT2 were therefore investigated by Q-RT-PCR with Figure 4C -D, both CA1 and GCNT2 were significantly reduced upon LIN28B-OE (CA1 -control: 5E+03 ± 4E+03 copies/ng, LIN28B-OE: 2E+03 ± 5E+02 copies/ng; p=0.01; GCNT2 -control: 1E+03 ± 3E+02 copies/ng, LIN28B-OE: 1E+02 ± 4E+01 copies/ng; p=0.01). Western analysis using anti-human CA1 antibody in LIN28B-OE compared to control samples at culture day 21 confirmed a reduction in CA1 levels; however, a major change in GCNT2 protein expression was not detected (Supplementary Figure 1A-B) .
LIN28B-OE. As shown in
LIN28B suppresses let-7 and miR-96 miRNAs. One characteristic effect of LIN28 proteins is the suppressed maturation of the let-7 family of miRNAs 21, 35 . Therefore, the expression patterns for several let-7 family members (let-7a, let-7b, let-7c, let-7d, let-7e, let-7f-2, let-7g and let-7i)
were investigated in LIN28B-OE erythroblasts. The let-7 family members demonstrated robust and consistent suppression with a greater than 70% reduction in LIN28B-OE compared to the control ( Figure 5A ). The chromatin modifier HMGA2 is a validated target of let-7 that also modulates growth and differentiation [36] [37] [38] . Retroviral integration of globin encoding vectors into the HMGA2 locus resulted in hematopoietic clonal dominance at the integration site as well as increased fetal hemoglobin expression 39 . Lin28 protein also increases the efficiency of insulin like growth factor 2 (IGF2) protein translation in muscle cells 20 . IGF2 is expressed at high levels in fetal hepatocytes and supports expansion of hematopoietic stem cells in fetal liver 40 LIN28B regulates BCL11A expression. Additional genetic mechanisms underlying gammaglobin expression and fetal hemoglobin (HbF) production were sought including the potential for LIN28B-OE to regulate erythroid transcription factors. BCL11A is an important transcriptional silencer of fetal hemoglobin in model systems as well as in humans 11, 26, 42 . KLF1 knockdown cells were reported to down-regulate BCL11A and activate gamma-globin 43 . In addition, SOX6 expression has been detected during erythroid development and implicated in playing a cooperative role with BCL11A in the regulation of gamma-globin 26 . The expression patterns of the transcription factors BCL11A, KLF1 and SOX6 were investigated, along with the erythroid transcription regulator, GATA1 ( Figure 5E-H) . Among the group, only BCL11A was affected by LIN28B-OE. LIN28B-OE caused a 65% reduction in BCL11A expression (control: 3.07E+03 ± 1.5 E+02 copies/ng, LIN28B-OE: 1.07E+03 ± 18 copies/ng; p=0.02, Figure 5E ).
Next, we investigated whether LIN28B and BCL11A regulate each other. In accordance with our mRNA expression data, LIN28B-OE down-regulated BCL11A at the protein level, as shown in Figure 6A -B. To investigate whether BCL11A modulates LIN28B expression, primary CD34+ cells were transduced with the shRNA lentivirus knockdown vector of BCL11A and lentiviral controls. BCL11A knockdown ( Figure 6C ) was evaluated and the results showed no effect on LIN28B expression ( Figure 6D ). 
Discussion
Increasing levels of fetal hemoglobin (HbF) in adult erythroblasts represents an important therapeutic target for patients with sickle cell disease (SCD) and β -thalassemias. In this study, we demonstrated that LIN28B regulates HbF levels during human erythroid cell development.
LIN28B knockdown in CD34+ cord blood cells significantly reduced HbF expression, and overexpression of LIN28B in adult erythroblasts significantly increased HbF levels. Interestingly, HbF levels were also increased in adult cells transduced with a separate vector encoding LIN28A. LIN28A and LIN28B are thus functionally similar in this regard. LIN28B is a more likely candidate as a physiological regulator of HbF, since LIN28B is expressed in fetal liver 27 and the gene possesses fetal-specific chromatin marks 26 in erythroid cells.
Since each cell's transcriptome helps determine its repertoire of RNA species that may be targeted by LIN28 proteins, the LIN28 effects upon cellular fate and phenotype are predicted to be variable. Genome-wide association studies (GWAS) identified LIN28 genes as regulators of Examination of LIN28B mRNA in cord blood erythroblasts suggests that low-level expression is sufficient to regulate let-7 and fetal hemoglobin in those cells. Significant reduction in fetal hemoglobin expression in cord blood erythroblasts was mediated by reductions in the erythroblast LIN28B mRNA levels (105 copies/ng reduced to 21 copies/ng). The effects of reducing LIN28B expression are thus amplified to regulate gamma-globin RNA levels that are normally detected at 5-log higher levels (10 7 copies/ng, see Figure 4B ). In the adult erythroblasts, LIN28A or LIN28B expression was below the detection limit in the control cultures. LIN28B overexpression in the adult cells reached levels that were approximately 100-fold higher than the cord blood erythroblasts (10 4 copies/ng, see Figure 2A ). The viral vector designs did not permit studies of adult derived erythroblasts that express LIN28B in the comparable range of cord blood cells. However, higher-level expression of the transduced LIN28B in the adult cells caused increases in fetal hemoglobin that approached, but did not
exceed, that of cord blood derived erythroblasts. The lack of increases in fetal hemoglobin above the cord blood levels, despite higher LIN28B expression, suggests saturation of the globin gene regulating effects in adult cells. These results may be relevant in the context of gene therapy applications 47 , since the requirements for high-level gamma-globin gene expression may be achieved via lower-level expression of a transduced gamma-globin gene regulator.
Our studies of LIN28B over-expression, as well as let-7 suppression in the absence of LIN28A or LIN28B, caused decreased expression of BCL11A as a predominant mechanism for increasing gamma-globin mRNA in the adult erythroblasts. Increased BCL11A was also detected after LIN28B-KD in the cord blood erythroblasts (data not shown). An initial GWAS suggested that the BCL11A locus accounts for approximately 15% of the HbF trait variance in European populations 7 . The role of BCL11A in globin gene regulation was confirmed experimentally using human erythroblasts 11 and genetically-modified mice 48 . Since neither BCL11A knockdown nor direct let-7 suppression had effects upon LIN28A or LIN28B expression, our data suggest that LIN28B affects the expression of fetal hemoglobin primarily by targeting let-7 to act as an upstream regulator of BCL11A. We did not observe changes in KLF1, GATA1, or SOX6 gene expression in response to LIN28B. In addition to binding and inhibiting let-7, LIN28 proteins may affect non-let-7 RNA species 25, 49, 50 ; however, our let-7 sponge studies suggest that the let-7 miRNAs are critical targets of LIN28 proteins. Nevertheless, systems biology approaches may be useful to more fully understand how LIN28 proteins and let-7 regulate the subset of genes described here as well as the overall erythroid phenotype.
Ultimately, these studies support the original hypothesis that regulated expression of the let-7 miRNA family is involved in hemoglobin switching during the fetal-to-adult transition of human ontogeny 24 .
Since let-7 and other microRNAs function by reducing the expression of the mRNA to which they bind, it is proposed that suppression of let-7 causes decreased expression of BCL11A by targeting other mRNA(s) that are expressed in human erythroblasts. While predicted erythroid mRNA targets of let-7 were reported previously 24 , the potential role for those genes in regulating BCL11A expression remains vague. 
